Protein level predicts immunotherapy response in bowel cancer
16th January 2025
Researchers have shown that the amount of a protein called CD74 can indicate which people with bowel cancer may respond best to immunotherapy.
Read more
Discovery of lingering DNA damage could change our understanding of cancer development
15th January 2025
Dr Michael Spencer Chapman and team have uncovered forms of DNA damage in healthy cells that can persist unrepaired for years
Read more
Surprising ‘two-faced’ cancer gene role supports paradigm shift in predicting disease
3rd January 2025
A genetic fault long believed to drive the development of oesophageal cancer may in fact play a protective role early in the disease, according to new research published in Nature Cancer.
Read more
Celebrating the BCI’s highlights of 2024
20th December 2024
Join us as we look back at some highlights of Barts Cancer Institute’s news stories this year.
Read more
Shining a Spotlight on AI Research at the Barts Cancer Institute
16th December 2024
We explore Nobel-Prize-winning research and the theory behind AI, and speak with Dr Vivek Singh, Dr Oscar Maiques and Professor Claude Chelala, three researchers using cutting-edge AI in their work at the BCI.
Read more
How non-cancerous cells in pancreatic cancer may weaken the immune system’s response
12th December 2024
New research sheds light on how certain non-cancerous cells in pancreatic cancer can affect the body’s natural immune defences and could have a significant impact on patients’ survival.
Read more